Arcadia BiosciencesRKDA

13F holders, Q2 2025 (June 30)
14holders
1new positions
1sold out
$4.38avg. 13F price*

At the end of Q2 2025, 14 institutions reported holding Arcadia Biosciences Inc. (RKDA) in their 13F filings, unchanged from Q1 2025. 1 opened new positions and 1 sold out. The largest holders were Mariner, LLC ($62K), Vanguard Group Inc. ($62K) and Geode Capital Management, LLC ($56K).

Company
Arcadia Biosciences Inc.
CUSIP
039014303
Latest filing quarter
Q2 2026

History

Number of 13F holders

05101520 Q1 2024: 13Q1 2024Q2 2024: 11Q2 2024Q3 2024: 13Q3 2024Q4 2024: 13Q4 2024Q1 2025: 14Q1 2025Q2 2025: 14Q2 2025Q3 2025: 16Q3 2025Q4 2025: 13Q4 2025Q1 2026: 15Q1 2026Q2 2026: 16Q2 2026

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions1$323
Exits1$3

All 13F filers, Q1 2025 → Q2 2025: 1,734 shares bought and 18,998 shares sold, net −17,264 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 14 holders

Mariner, LLC 0.00% Reduce -47.2% 14,500 $62K
Vanguard Group Inc. 0.00% No change 14,038 $62K
Geode Capital Management, LLC 0.00% No change 12,795 $56K
State Street Corp. 0.00% No change 12,146 $54K
UBS Group AG 0.00% Reduce -70.3% 2,544 $11K
Tower Research Capital LLC (TRC) 0.00% Add +338.2% 1,915 $8K
Morgan Stanley 0.00% Add +29.4% 787 $3K
Atticus Wealth Management, LLC 0.00% No change 272 $1K
SBI Securities Co., Ltd. 0.00% No change 120 $517
Osaic Holdings, Inc. 0.00% New 75 $323
Group One Trading LLC 0.00% No change 18 $79
Bank of America Corp. 0.00% Add +18.2% 13 $56
Assetmark, Inc. 0.00% No change 5 $22
Harbour Investments, Inc. 0.00% No change 1 $4

"% of holder's portfolio" is RKDA's weight in each manager's 13F, not the share of Arcadia Biosciences Inc. the manager owns.